Boragen Adds Dr. Mark Zettler to Growing Scientific Advisory Board
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Dec 17, 2019--
Boragen Inc., a world-leading boron-based discovery platform, today announced that it has added Dr. Mark Zettler to its Scientific Advisory Board. Dr. Zettler brings over 30 years of leadership experience across the global pre- and post-harvest food and agriculture industries.
“I am honored to serve Boragen in this capacity,” said Dr. Zettler. “I’m confident that Boragen’s impressive leadership, talented scientific team and novel technology will continue to deliver innovative solutions to unmet industry needs.”
Dr. Zettler has held multiple leadership positions in R&D and New Business Development for Dow Chemical, Dow AgroSciences and AgroFresh Solutions. In these roles, he has overseen the discovery, development, regulatory approval and launch of new active ingredients and formulated products. These solutions spanned agronomic and horticultural crops, from grower to retailer. Currently, Dr. Zettler is an advisor and strategist for food and ag tech startups and investors.
Boragen Crop Protection Scientific Advisory Board provides external scientific review for Boragen Research and Development activities, evaluating research programs and progress. The Board is chaired by Dr. Roger Kemble, former President of Syngenta Biotechnology, Inc.
“Mark’s extensive history in this field makes him an extremely valuable addition to Boragen’s Scientific Advisory Board,” said Dr. Kemble. “I look forward to working with him as we support and guide Boragen’s mission.”
Boragen’s Scientific Advisory board is comprised of distinguished scientists with expertise relevant to the company’s scientific goals, including the discovery and development of boron-based platform technology for applications in agriculture and animal and human health. Members currently include Dr. Peter Hertl, former Head of Global Regulatory and Product Safety for Syngenta, Dr. Jake Plattner, former Sr. Vice President of Research for Anacor Pharmaceuticals and Dr. Robert Steffens, former Vice President of Product Development for Bayer.
Boragen’s mission is to utilize a robust and extensive intellectual property portfolio to refine the unique characteristics of boron, delivering novel chemistry solutions. The company was founded by Dr. Tony Liu, CSO, Dr. Lucy Shapiro, Dr. Stephen Benkovic, Dr. Gerry Fink and Dr. Paul Schimmel.
Boragen, founded in 2015 by world-renowned experts in boron chemistry, is headquartered in Research Triangle Park, North Carolina. The company utilizes boron’s unique properties to design and develop novel solutions targeting needs in crop protection, animal health and human health. To date, the company has developed a unique boron-based screening library targeting diverse biological applications. For more information visit www.boragenbio.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20191217005505/en/
CONTACT: Kristi Lee-John
Crossroads B2B for Boragen
KEYWORD: UNITED STATES NORTH AMERICA NORTH CAROLINA
INDUSTRY KEYWORD: RESEARCH CLINICAL TRIALS BIOTECHNOLOGY HEALTH PHARMACEUTICAL AGRICULTURE OTHER SCIENCE SCIENCE NATURAL RESOURCES
SOURCE: Boragen Inc.
Copyright Business Wire 2019.
PUB: 12/17/2019 09:00 AM/DISC: 12/17/2019 09:01 AM